scorecardresearch
CORONAVIRUS

CORONAVIRUS

Inside China's fight over the future of zero-COVID (Photo: Reuters)

Inside China's fight over the future of zero-COVID

Dec 02, 2022

Opinions about President Xi Jinping's signature "zero-COVID" policy vary wildly across China, a country often viewed from overseas as a surveillance state that enforces iron discipline.

That is compared with 36,061 new cases a day earlier – 4,150 symptomatic and 31,911 asymptomatic infections, which China counts separately.

China reports 34,980 new COVID cases for Dec 1 vs 36,061 a day earlier

Dec 02, 2022

Excluding imported infections, China reported 34,772 new local cases, of which 4,233 were symptomatic and 30,539 were asymptomatic, down from 35,800 a day earlier.

Vaccine dose/Representative image

DCGI approves Bharat Biotech’s intranasal heterologous ‘Five Arms’ COVID-19 booster dose

Nov 25, 2022

Bharat Biotech had applied for the market authorisation of the intranasal heterologous booster in September.

During this period, death rates among people aged 6 months and above stood around six times higher than the rate of those who received their primary shots.

58% of Americans dying due to COVID-19 were either vaccinated or boosted: Report

Nov 25, 2022

COVID-19 in the US: August was also the time when the BA.5 variant reached its peak.

The pathogen list was first published in 2017 and the last prioritisation exercise was done in 2018.

What is Disease X and why is WHO keeping a close watch?

Nov 23, 2022

The Disease X has been identified as an unknown pathogen that has the potential to cause a serious international epidemic, according to the World Health Organization.

Novavax also has a pact with the Serum Institute of India for manufacturing a version of the vaccine under the brand Covovax

Novavax ends COVID vaccine sale agreement with Gavi

Nov 22, 2022

The company cited Gavi's failure to procure the 350 million doses it had agreed to buy in May last year for the COVAX facility.

Bharat Biotech said Covaxin is one of the most highly studied Covid-19 vaccines worldwide and that it was evaluated in more than 20 pre-clinical studies, including three challenge trials and nine human clinical studies

Bharat Biotech, Health Ministry rubbish claims that Covaxin was ‘rushed due to political pressure’

Nov 17, 2022

Covaxin makers Bharat Biotech also in a statement said that the targeted narrative against Covaxin is misleading and asserted that there was no external pressure to accelerate the development of Covaxin. The company clarified that the pressure was all internal to develop a safe, and effective vaccine for the Covid-19 pandemic.

According to the report, tens of millions have died from the COVID-19 virus worldwide. In addition to the tragic loss of life, over the past three years, we have experienced the social, educational, and economic costs of a global pandemic.

Covid outbreak likely due to China's Wuhan lab leak, claims US Senate report

Oct 28, 2022

In an interim report, titled ‘An Analysis of the Origins of the COVID-19 Pandemic,’ the US Senate Republicans investigated the origin of the COVID virus and explained how it could have started from a laboratory leak.

Going forward, when people take a few shots every year, they may take anti-coronavirus vaccines and other shots together, Poonawalla said, adding, "It will become that kind of a product."

SII stopped Covishield production in Dec 2021, says CEO Adar Poonawalla

Oct 21, 2022

"Since December 2021, we stopped the production (of Covishield). We had a stock of a few hundred million doses at that time and of that, 100 million doses have already expired," said Poonawalla when asked about the update on the Covishield vaccine.

Pfizer said it expects the COVID-19 market to be about the size of the flu shot market on an annual basis for adults, but that the pediatric market would take longer to build based on shots given so far.

Pfizer expects to hike US COVID vaccine price to $110-$130 per dose

Oct 21, 2022

Lukin said she expects the vaccine - currently provided for free to all by the government - will be made available at no cost to people who have private insurance or government paid insurance.

Shoppers have thronged the streets amid restrictions being lifted including the mandatory use of masks.

Delhi government withdraws Rs 500 fine for not wearing masks ahead of Diwali

Oct 20, 2022

This comes at a time when Delhi’s markets, which include such crowded places like the Sadar Bazaar, are witnessing a heavy footfall.

WHO says COVID-19 is still a global health emergency (Photo: Reuters)

WHO says COVID-19 is still a global health emergency

Oct 20, 2022

The WHO's emergency committee first made the declaration for COVID-19 on Jan 30, 2020. Such a determination can help accelerate research, funding and international public health measures to contain a disease.

India sees rise in Covid-19 cases, Maharashtra govt warns of XXB variant reaching its peak in mid-November (Photo: Reuters)

India sees rise in Covid-19 cases, Maharashtra govt warns of XXB variant reaching its peak in mid-November

Oct 19, 2022

According to the Maharashtra Health Department, the XXB variant of covid-19 will reach its peak in mid-November, after the festivities are over. Maharashtra has recorded 18 cases of XBB sub-variant of Omicron detected in 15 days.

BQ.1 and B.Q.1.1 are sub-variants of BA.5, which is responsible for 60 per of Covid cases in the US at present. Photo: Reuters

Pune reports first case of new Omicron subvariant ahead of Diwali festivities

Oct 18, 2022

India on Tuesday recorded a single-day rise of 1,542 coronavirus infections, which is its lowest in last six months. The active cases comprise 0.06 per cent of the total infections, while the national Covid-19 recovery rate has increased to 98.76 per cent

One in 20 people suffer long-term effects of COVID-19: Study (Photo: Reuters)

One in 20 people suffer long-term effects of COVID-19: Study

Oct 13, 2022

The Long-CISS (COVID In Scotland Study) -- found that 1 in 20 people who took part in the research had not recovered from having COVID-19 at their most recent follow up -- between six and 18 months following infection with SARS-CoV-2.

This year has been the first real opportunity for both viruses to circulate freely as all COVID restrictions have now been lifted.

Flu is set for a big comeback now COVID restrictions are lifted; what you need to know

Oct 08, 2022

Despite the continuous circulating of new variants and sub-variants, the COVID vaccine continues to provide high protection against severe disease and death. The strains of flu also change each winter and are, to some extent, unpredictable.

World Health Organisation

‘Consider global COVID declining trend with caution,’ warns WHO

Oct 03, 2022

India’s active caseload currently stands at 36,126. Active cases now constitute 0.08 per cent of the country's total Positive Cases, according to union health ministry data. At least 3,011 new cases were reported in the last 24 hours.

More than 76.18 lakh first dose, 2.35 crore second dose and 15.92 crore precaution dose have been administered in this period of 75 days.

From airports to bus stops: How India scaled up Covid-19 vaccinations in a 75-day-campaign

Sep 30, 2022

“Administration of Precaution Dose is pivotal to confer full/extended protection to beneficiaries against Covid-19. It helps to reduce the severity of the COVID-19 disease, risk of hospitalization and thereby reduces mortality,” said the government.

 Sense of an ending: Scientists say worst of Covid-19 could be over (Photo: Reuters)

Sense of an ending: Scientists say worst of Covid-19 could be over

Sep 23, 2022

The pandemic will be over but Covid will be here to stay, the scientists said as Covid numbers begin to ebb in several parts of the world, including India.

The source said Prime Minister Justin Trudeau was "likely" to drop the vaccination requirement on Sept 30

Canada to drop COVID vaccine requirement to enter country on Sept 30

Sep 21, 2022

Canadian airports faced chaos over the summer, with numerous cancellations and delays that some blamed on the country's strict COVID-19 restrictions. 

In August, the FDA authorized Pfizer and Moderna's updated booster shots that target the dominant BA.4 and BA.5 Omicron subvariants, as the country prepares for a broad fall revaccination campaign.

US delivers over 25 mn COVID boosters; Moderna's shot in limited supply

Sep 21, 2022

In a statement late on Tuesday, the US Food and Drug Administration (FDA) said it authorized ten batches of Moderna's updated booster shots.